 <h1>Phenelzine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to phenelzine: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of phenelzine sulfate or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Phenelzine sulfate is not approved for use in pediatric patients.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, phenelzine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking phenelzine:</p><p>
<i>More common</i>
</p><ul>
<li>Chills</li>
<li>cold sweats</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position</li>
<li>overactive reflexes</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>sudden jerky movements of the body</li>
<li>swelling</li>
<li>trembling or shaking of the hands or feet</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>actions that are out of control</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>change in consciousness</li>
<li>clay-colored stools</li>
<li>dark urine</li>
<li>decrease in frequency of urination</li>
<li>decrease in urine volume</li>
<li>difficult or troubled breathing</li>
<li>difficulty in passing urine (dribbling)</li>
<li>disorganized thoughts</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>false or unusual sense of well-being</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>fear or nervousness</li>
<li>fever</li>
<li>general feeling of discomfort, illness, or weakness</li>
<li>headache</li>
<li>high blood pressure</li>
<li>increased sweating</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>irritability</li>
<li>itching</li>
<li>lack of emotion or feelings</li>
<li>loss of appetite</li>
<li>loss of consciousness</li>
<li>loud or fast speech</li>
<li>low blood pressure</li>
<li>muscle tremors</li>
<li>muscle twitching</li>
<li>nausea or vomiting</li>
<li>nervousness</li>
<li>no emotion or expression in speech</li>
<li>painful urination</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>rapid, deep, or shallow breathing</li>
<li>rash</li>
<li>restlessness</li>
<li>seeing or hearing things that are not there</li>
<li>seizures</li>
<li>shakiness and unsteady walk</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>stomach cramps</li>
<li>sweating</li>
<li>swelling of the feet or lower legs</li>
<li>talking, feeling, and acting with excitement</li>
<li>uncontrolled eye movements</li>
<li>unpleasant breath odor</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>unusual paleness</li>
<li>unusual tiredness or weakness</li>
<li>vomiting of blood</li>
<li>weakness</li>
<li>yellow eyes or skin </li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of phenelzine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
<li>decreased interest in sexual intercourse</li>
<li>diarrhea</li>
<li>dry mouth</li>
<li>inability to have or keep an erection</li>
<li>indigestion</li>
<li>loss in sexual ability, desire, drive, or performance</li>
<li>loss of appetite</li>
<li>not able to have an orgasm</li>
<li>passing of gas</li>
<li>sleeplessness</li>
<li>stomach pain, fullness, or discomfort</li>
<li>trouble sleeping</li>
<li>unable to sleep</li>
<li>unusually deep sleep</li>
<li>unusually long duration of sleep</li>
<li>weight gain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blindness</li>
<li>blurred vision</li>
<li>decreased vision</li>
<li>eye pain</li>
<li>redness, swelling, or soreness of the tongue</li>
<li>tearing</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phenelzine: oral tablet</i></p><h3>General</h3><p>The most important adverse event reported is hypertensive crisis, which has been associated with intracranial bleeding and has been fatal.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, drowsiness, headache, hyperreflexia, myoclonic movements, tremors</p>
<p><b>Uncommon</b> (0.1% to 1%): Convulsions, palilalia, paresthesia, peripheral neuritis</p>
<p><b>Rare</b> (0.01% to 0.1%): Acute dystonic reaction, ataxia, coma, neuroleptic malignant syndrome (occasionally fatal), sensorimotor peripheral neuropathy, shock-like coma, speech blockade, transient respiratory and cardiovascular depression following ECT</p>
<p><b>Frequency not reported</b>: Intracranial bleeding/fatal intracranial bleeding, occipital headache/occipital headache which may radiate frontally<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anorgasmia, hypersomnia, hypomania, insomnia, sleep disturbances</p>
<p><b>Uncommon</b> (0.1% to 1%): Agitation, behavioral changes, confusion, euphoria, frank psychosis, hallucinations, nervousness, vivid nightmares</p>
<p><b>Rare</b> (0.01% to 0.1%): Acute anxiety reaction, delusional parasitosis, manic reaction, precipitation of schizophrenia, toxic delirium</p>
<p><b>Frequency not reported</b>: suicidal behaviors, suicidal ideation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, dry mouth, gastrointestinal disturbances, nausea, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Anorgasmia, ejaculatory disturbances, impotence, sexual disturbances</p>
<p><b>Uncommon</b> (0.1% to 1%): Delayed ejaculation, difficulty in micturition, urinary retention<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Adverse effects on driving ability, fatigue, weakness</p>
<p><b>Uncommon</b> (0.1% to 1%): Jitteriness, withdrawal/withdrawal syndrome</p>
<p><b>Rare</b> (less than 0.1%): Fever associated with increased muscle tone, hyperpyrexia, malaise<sup>[Ref]</sup></p><p>Withdrawal may be associated with nausea, vomiting, and malaise.</p>
<p></p>
<p>Withdrawal syndrome occurred after abrupt drug discontinuation, and generally started after 24 to 72 hours; signs/symptoms varied from vivid nightmares and agitation to frank psychosis and convulsions.  The withdrawal syndrome generally responded to reinstitution of low dose therapy, followed by cautious downward titration and discontinuation.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Edema, postural hypotension</p>
<p><b>Uncommon</b> (0.1% to 1%): Arrhythmias</p>
<p><b>Rare</b> (0.01% to 0.1%): Blood pressure changes, tachycardia</p>
<p><b>Frequency not reported</b>: Bradycardia, constricting chest pain, hypertensive crisis, palpitation<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypernatremia, increased appetite</p>
<p><b>Rare</b> (0.01% to 0.1%): Hypermetabolic syndrome, metabolic acidosis</p>
<p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><p>Hyponatremia may be more likely to occur in older patients or in those with inappropriate secretion of antidiuretic hormone; this side effect should be considered in patients treated with antidepressants who present with confusion, convulsions, and/or drowsiness.</p>
<p></p>
<p>Hypermetabolic syndrome may resemble signs/symptoms of an overdose.<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p>
<p><b>Uncommon</b> (0.1% to 1%): Glaucoma, nystagmus</p>
<p><b>Frequency not reported</b>: Dilated pupils, photophobia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Twitching</p>
<p><b>Uncommon</b> (0.1% to 1%): Muscle tremor</p>
<p><b>Rare</b> (0.01% to 0.1%): Elevated creatine kinase levels, muscular rigidity</p>
<p><b>Frequency not reported</b>: Neck soreness, neck stiffness<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Elevated serum transaminases (without accompanying signs/symptoms)</p>
<p><b>Uncommon</b> (0.1% to 1%): Elevated liver enzymes</p>
<p><b>Rare</b> (less than 0.1%): Fatal progressive necrotizing hepatocellular damage, reversible jaundice<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, purpura, rash/skin rash, sweating</p>
<p><b>Frequency not reported</b>: Sweating with cold, clammy skin or fever<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Blood dyscrasias</p>
<p><b>Rare</b> (less than 0.1%): Leucopenia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lupus-like illness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (0.01% to 0.1%): Hypoxia, tachypnea<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Edema of the glottis<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (0.01% to 0.1%): Inappropriate secretion of antidiuretic hormone/ADH secretion<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Nardil (phenelzine)." Parke-Dvis, Morris Plains, NJ. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What are some common side effects of antidepressants?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about phenelzine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>119 Reviews</li>
<li>Drug class: monoamine oxidase inhibitors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Phenelzine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Nardil</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Depression</li>
<li>Migraine Prevention</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to phenelzine: oral tablet</i></p><h3>General</h3><p>The most important adverse event reported is hypertensive crisis, which has been associated with intracranial bleeding and has been fatal.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, drowsiness, headache, hyperreflexia, myoclonic movements, tremors</p><p><b>Uncommon</b> (0.1% to 1%): Convulsions, palilalia, paresthesia, peripheral neuritis</p><p><b>Rare</b> (0.01% to 0.1%): Acute dystonic reaction, ataxia, coma, neuroleptic malignant syndrome (occasionally fatal), sensorimotor peripheral neuropathy, shock-like coma, speech blockade, transient respiratory and cardiovascular depression following ECT</p><p><b>Frequency not reported</b>: Intracranial bleeding/fatal intracranial bleeding, occipital headache/occipital headache which may radiate frontally<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anorgasmia, hypersomnia, hypomania, insomnia, sleep disturbances</p><p><b>Uncommon</b> (0.1% to 1%): Agitation, behavioral changes, confusion, euphoria, frank psychosis, hallucinations, nervousness, vivid nightmares</p><p><b>Rare</b> (0.01% to 0.1%): Acute anxiety reaction, delusional parasitosis, manic reaction, precipitation of schizophrenia, toxic delirium</p><p><b>Frequency not reported</b>: suicidal behaviors, suicidal ideation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Constipation, dry mouth, gastrointestinal disturbances, nausea, vomiting<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Anorgasmia, ejaculatory disturbances, impotence, sexual disturbances</p><p><b>Uncommon</b> (0.1% to 1%): Delayed ejaculation, difficulty in micturition, urinary retention<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Adverse effects on driving ability, fatigue, weakness</p><p><b>Uncommon</b> (0.1% to 1%): Jitteriness, withdrawal/withdrawal syndrome</p><p><b>Rare</b> (less than 0.1%): Fever associated with increased muscle tone, hyperpyrexia, malaise<sup>[Ref]</sup></p><p>Withdrawal may be associated with nausea, vomiting, and malaise.</p><p></p><p>Withdrawal syndrome occurred after abrupt drug discontinuation, and generally started after 24 to 72 hours; signs/symptoms varied from vivid nightmares and agitation to frank psychosis and convulsions.  The withdrawal syndrome generally responded to reinstitution of low dose therapy, followed by cautious downward titration and discontinuation.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Edema, postural hypotension</p><p><b>Uncommon</b> (0.1% to 1%): Arrhythmias</p><p><b>Rare</b> (0.01% to 0.1%): Blood pressure changes, tachycardia</p><p><b>Frequency not reported</b>: Bradycardia, constricting chest pain, hypertensive crisis, palpitation<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain</p><p><b>Uncommon</b> (0.1% to 1%): Hypernatremia, increased appetite</p><p><b>Rare</b> (0.01% to 0.1%): Hypermetabolic syndrome, metabolic acidosis</p><p><b>Frequency not reported</b>: Hyponatremia<sup>[Ref]</sup></p><p>Hyponatremia may be more likely to occur in older patients or in those with inappropriate secretion of antidiuretic hormone; this side effect should be considered in patients treated with antidepressants who present with confusion, convulsions, and/or drowsiness.</p><p></p><p>Hypermetabolic syndrome may resemble signs/symptoms of an overdose.<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision</p><p><b>Uncommon</b> (0.1% to 1%): Glaucoma, nystagmus</p><p><b>Frequency not reported</b>: Dilated pupils, photophobia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Twitching</p><p><b>Uncommon</b> (0.1% to 1%): Muscle tremor</p><p><b>Rare</b> (0.01% to 0.1%): Elevated creatine kinase levels, muscular rigidity</p><p><b>Frequency not reported</b>: Neck soreness, neck stiffness<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Elevated serum transaminases (without accompanying signs/symptoms)</p><p><b>Uncommon</b> (0.1% to 1%): Elevated liver enzymes</p><p><b>Rare</b> (less than 0.1%): Fatal progressive necrotizing hepatocellular damage, reversible jaundice<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Uncommon</b> (0.1% to 1%): Pruritus, purpura, rash/skin rash, sweating</p><p><b>Frequency not reported</b>: Sweating with cold, clammy skin or fever<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Uncommon</b> (0.1% to 1%): Blood dyscrasias</p><p><b>Rare</b> (less than 0.1%): Leucopenia<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lupus-like illness<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Rare</b> (0.01% to 0.1%): Hypoxia, tachypnea<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Edema of the glottis<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Rare</b> (0.01% to 0.1%): Inappropriate secretion of antidiuretic hormone/ADH secretion<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Nardil (phenelzine)." Parke-Dvis, Morris Plains, NJ. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What are some common side effects of antidepressants?</li>
</ul><h2>More about phenelzine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>119 Reviews</li>
<li>Drug class: monoamine oxidase inhibitors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Phenelzine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Depression</li>
<li>Migraine Prevention</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>